• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients

tetano

Editor, Senior Moderator
PLoS Pathog. 2017 Oct 12;13(10):e1006650. doi: 10.1371/journal.ppat.1006650. eCollection 2017 Oct.
[h=1]Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients.[/h] Vasilijevic J[SUP]1,[/SUP][SUP]2[/SUP], Zamarre?o N[SUP]1,[/SUP][SUP]2[/SUP], Oliveros JC[SUP]3[/SUP], Rodriguez-Frandsen A[SUP]1,[/SUP][SUP]2[/SUP], G?mez G[SUP]1[/SUP], Rodriguez G[SUP]4[/SUP], P?rez-Ruiz M[SUP]5[/SUP], Rey S[SUP]6[/SUP], Barba I[SUP]7[/SUP], Pozo F[SUP]8[/SUP], Casas I[SUP]8[/SUP], Nieto A[SUP]1,[/SUP][SUP]2[/SUP], Falc?n A[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A virus (IAV) infection can be severe or even lethal in toddlers, the elderly and patients with certain medical conditions. Infection of apparently healthy individuals nonetheless accounts for many severe disease cases and deaths, suggesting that viruses with increased pathogenicity co-circulate with pandemic or epidemic viruses. Looking for potential virulence factors, we have identified a polymerase PA D529N mutation detected in a fatal IAV case, whose introduction into two different recombinant virus backbones, led to reduced defective viral genomes (DVGs) production. This mutation conferred low induction of antiviral response in infected cells and increased pathogenesis in mice. To analyze the association between low DVGs production and pathogenesis in humans, we performed a genomic analysis of viruses isolated from a cohort of previously healthy individuals who suffered highly severe IAV infection requiring admission to Intensive Care Unit and patients with fatal outcome who additionally showed underlying medical conditions. These viruses were compared with those isolated from a cohort of mild IAV patients. Viruses with fewer DVGs accumulation were observed in patients with highly severe/fatal outcome than in those with mild disease, suggesting that low DVGs abundance constitutes a new virulence pathogenic marker in humans.


PMID: 29023600 DOI: 10.1371/journal.ppat.1006650
 
Back
Top Bottom